Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Acuren Q4 Sales $313.925M Beat $308.405M Estimate

Author: Benzinga Newsdesk | August 14, 2025 07:04am
Acuren (NYSE:TIC) reported quarterly sales of $313.925 million which beat the analyst consensus estimate of $308.405 million by 1.79 percent. This is a 1.50 percent increase over sales of $309.292 million the same period last year.

Posted In: TIC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist